Fundely
3137
Axel Mark
3624
Twenty-four seven
7074
Visumo
303A
Nomura Micro Science
6254
(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|
Total revenue | -0.34%23.04B | -3.07%7.22B | -3.17%5.68B | 5.31B | 4.84B | 23.12B | 7.45B | 5.86B |
Cost of revenue | 2.74%16.96B | 1.20%5.42B | -0.88%4.11B | 3.91B | 3.52B | 16.51B | 5.36B | 4.15B |
Gross profit | -8.03%6.08B | -14.02%1.8B | -8.72%1.56B | 1.4B | 1.32B | 6.61B | 2.09B | 1.71B |
Operating expense | -4.08%4.74B | -11.06%1.3B | 0.63%1.18B | 1.12B | 1.15B | 4.94B | 1.46B | 1.17B |
Operating profit | -19.72%1.34B | -20.81%502.59M | -28.84%386.24M | 285.3M | 167.57M | 1.67B | 634.64M | 542.78M |
Net non-operating interest income (expenses) | -136.53%-5.8M | -138.76%-2.39M | -667.07%-1.28M | -1.76M | -365K | -2.45M | -1M | -167K |
Non-operating interest income | -31.93%5.39M | -48.18%939K | -53.70%1.17M | --886K | --2.4M | --7.92M | --1.81M | --2.53M |
Non-operating interest expense | 7.86%11.19M | 18.34%3.33M | -9.05%2.45M | --2.65M | --2.76M | --10.37M | --2.81M | --2.7M |
Net investment income | -18.28%101.97M | 353.87%14.64M | -55.18%35.71M | 12.33M | 39.3M | 124.78M | 3.23M | 79.68M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -488.21%-14.72M | 205.56%4.03M | -12,280.00%-14.86M | -489K | -3.41M | -2.5M | -3.82M | -120K |
Income from associates and other participating interests | ||||||||
Special income (charges) | -83.53%14.07M | -87.62%15.46M | 97.27%-999K | -174K | -213K | 85.42M | 124.87M | -36.63M |
Less:Other special charges | 83.53%-14.07M | 87.62%-15.46M | -97.27%999K | --174K | --213K | ---85.42M | ---124.87M | --36.63M |
Other non-operating income (expenses) | 84.48%50.7M | 264.49%13.77M | -44.63%6.15M | 15.2M | 15.59M | 27.48M | -8.37M | 11.1M |
Income before tax | -21.85%1.49B | -26.88%548.09M | -31.12%410.96M | 310.4M | 218.48M | 1.9B | 749.55M | 596.64M |
Income tax | -10.92%539.29M | -16.62%236.09M | -10.97%144.01M | 109.09M | 50.1M | 605.39M | 283.16M | 161.75M |
Net income | -26.95%948.64M | -33.10%312M | -38.62%266.95M | 201.31M | 168.38M | 1.3B | 466.4M | 434.89M |
Net income continuous operations | -26.95%948.64M | -33.10%312M | -38.62%266.95M | --201.31M | --168.38M | --1.3B | --466.4M | --434.89M |
Noncontrolling interests | -25.19%254.46M | -39.40%90.98M | -37.68%57.75M | 50.99M | 54.74M | 340.16M | 150.13M | 92.67M |
Net income attributable to the company | -27.57%694.17M | -30.12%221.02M | -38.87%209.2M | 150.32M | 113.64M | 958.37M | 316.27M | 342.22M |
Preferred stock dividends | ||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -27.57%694.17M | -30.12%221.02M | -38.87%209.2M | 150.32M | 113.64M | 958.37M | 316.27M | 342.22M |
Gross dividend payment | ||||||||
Basic earnings per share | -27.57%115.72 | -30.10%36.85 | -38.88%34.87 | 25.06 | 18.94 | 159.76 | 52.72 | 57.05 |
Diluted earnings per share | -27.57%115.72 | -30.11%36.8438 | -38.88%34.87 | 25.0579 | 18.94 | 159.76 | 52.72 | 57.0473 |
Dividend per share | 0.00%7.5 | 0.00%3.75 | 0 | 3.75 | 0 | 7.5 | 3.75 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |